In addition
to the positive reports gathered from medical practice
on the benefits of CH-Alpha, there is a series of
clinical studies showing the effects of CH-Alpha in
enhancing joint function and improving joint health.
|
|
|
|
| Krug |
1979 |
193 |
open |
| Gotz |
1982 |
60 |
open |
| Oberschelp |
1985 |
154 |
comparative |
| Seeligmüller |
1989 |
356 |
open |
| Adam |
1991 |
81 |
double-blind, crossover |
| Seeligmüller |
1993 |
519 |
open |
| Beuker, Eck |
1996 |
40 |
open |
| Beuker, Rosenfeld |
1996 |
100 |
double-blind |
| Ribas Fernández, Molinero Pérez |
1998 |
26 |
comparative |
| Moskowitz |
2000 |
389 |
double-blind |
| Rippe |
2004 |
250 |
double-blind |
| Rippe |
2005 |
102 |
randomized |
| Flechsenhar, Alf |
2005 |
100 |
open |
| Adam |
submitted for publication |
45 |
comparative, double-blind |
Adam
This randomized double-blind study involving 81 patients assessed changes in symptoms after patients received collagen hydrolysate, gelatin, egg albumin, or gelatin + glycine + calcium hydroxylate.1 A 2-month washout phase alternated with a therapy period of 2 months. The study was conducted over 16 months. In all, 52 patients received the different treatment forms in a randomized, double-blind sequence. Evaluation showed that treatment with collagen hydrolysate produced a clear, statistically relevant improvement in test parameters, such as mobility, compared with the control group.
Moskowitz
This randomized multicenter study was conducted between 1996 and 1998 at 20 sites in the United States, the United Kingdom, and Germany over 24 weeks.2 A total of 389 patients were assessed to determine if improvements in physical function or overall/global response were demonstrated after receiving collagen hydrolysate compared with placebo. Collagen hydrolysate was shown to have a positive effect even though there were considerable differences between the countries involved. In the German population, the positive results were particularly impressive: patients confirmed an improvement in physical function and there was a trend to significance in the patient global assessment. Concomitant medication (especially analgesics), as well as high dropout rates, may explain the different results obtained in the different countries.
| |
|
|
|
| Physical function |
P = 0.46 |
P = 0.75 |
P = 0.007 |
| Patient global |
P = 0.76 |
P = 0.15 |
P = 0.074 |
| Mean score differences from baseline showed that collagen hydrolysate offered a statistically significant advantage over placebo when physical function was assessed.2 |
Rippe et al
The results of a randomized, prospective, double-blind study in 250 (190 evaluable) mild osteoarthritis patients showed that the administration of collagen hydrolysate considerably improved the function of the knee joints.3 The effect of collagen hydrolysate was examined over a period of 14 weeks in comparison to a control group given placebo. (Please note, in this study, collagen hydrolysate was given in conjunction with calcium [300 mg] and vitamin C [60 mg]). Many parameters were assessed relating to joint function and mobility. The findings suggest collagen hydrolysate may contribute to early improvement in knee function.
An additional, similar study by Rippe et al, showed that the administration of collagen hydrolysate also considerably improved knee joint function in severe osteoarthritis patients.4
Götz
This non-randomized study tested the effect of collagen hydrolysate in 60 patients over 3 months.5 Subjective and objective measures were investigated to evaluate the effect of collagen hydrolysate. After 1 month, 56% of patients had improved considerably. At the end of the study, 75% of patients were either symptom-free (45%) or had clearly improved symptoms (30%).
Fernández et al
To evaluate the effects of collagen hydrolysate in athletes, a 6-month study of a 16-member team of mountain bike competitors and 10 individuals of a basketball team from the first division of a Spanish league.6 Each study participant was given a single daily dose of 10 g of collagen hydrolysate plus vitamin B and magnesium.
Upon completion of the study, patients in the study group demonstrated statistically significant increases in the thickness of cartilage of the scapula-humeral joint and the femora-tibial joint.6 The average increase in cartilage thickness was 14% in the study group. Conversely, not only was there no increase in cartilage thickness in the control group after 6 months, significant decreases were observed. In the control group, the lateral and medial scapula-humeral joint cartilage showed a 16% and 13% decrease in thickness respectively (P<0.05).
|
|
| Intercondylar recess |
5% |
| Medial femora-condyle |
13% (P<0.05) |
| Lateral femora-condyle |
27% (P<0.05) |
| Humeral head, central zone |
11% (P<0.05) |
| Humeral head, lateral zone |
16% (P<0.05) |
| Humeral head, medial zone |
14% (P<0.05) |
Flechsenhar et al
The effect of CH-Alpha™ on
athletes reporting joint symptoms was also evaluated
in this post-surveillance study of 100 athletes at
the Rhein-Ruhr Olympic Training Facilities in Essen,
Germany.7 Subjects took 10 g of CH-Alpha
daily for 12 weeks and were asked to rate symptoms
and functionality according to a 10-point scale. Assessments
were gathered at the beginning of the study (to establish
a baseline), 4 to 6 weeks later, and at the end of
the study. Significant improvements were reported
for the clinical parameters.
Additional Evidence
Empirical reports by Krug (1979) as well as others such as those by Seeligmüller et al (1989, 1993), Beuker et al (1996), and Weh (2001) indicate that collagen hydrolysate is a safe and efficacious supplement for use in patients suffering from chronic joint symptoms.8-12
 |